Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹1,063 Cr₹337 Cr₹361 Cr₹384 Cr₹271 Cr

What is the latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹1,063 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹1,063 Cr
Mar2023₹337 Cr
Mar2022₹361 Cr
Mar2021₹384 Cr
Mar2020₹271 Cr

How is Contingent Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2024 ₹1,063 Cr
215.81
Mar2023 ₹337 Cr
-6.81
Mar2022 ₹361 Cr
-5.96
Mar2021 ₹384 Cr
41.66
Mar2020 ₹271 Cr -

Compare Contingent Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,403.5 Cr -0.8% 25% 50.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,595.0 Cr 1.5% 0.9% 2% Stock Analytics
DIVIS LABORATORIES ₹174,635.0 Cr -0.5% -1.2% 45.5% Stock Analytics
CIPLA ₹126,894.0 Cr 7.2% 4.5% 2.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,685.0 Cr 3.5% 8.4% 16.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,373.0 Cr 3.7% -1.1% -6.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.8%

25%

50.6%

SENSEX

-1.6%

-3.4%

0.9%


You may also like the below Video Courses